Class IITerminatedD-0974-2020
Drug recall · March 11, 2020
MIC-PLEX Injection recall
Why: Lack of Assurance of Sterility
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
MIC-PLEX Injection, Vitamin Complex, MIC-COMBO* 25MG/50MG/50MG/1MG/20MG/5MG/ML INJECTABLE, For IM Use, Protect From Light, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0233-3
- Lots / codes
Lot #: 11212019+53263, Exp 2/16/2020; 11252019+53276, Exp 2/20/2020
- Quantity
- N/A
- Company
- Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical, Los Angeles, CA
- Distribution
- U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic
- Initiated
- January 15, 2020 · Voluntary: Firm initiated
- Classified
- March 5, 2020
- Reported
- March 11, 2020
- Ended
- December 7, 2023
- How notified
- Press Release
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Class IITerminatedMar 11, 2020Alprostadil/Papaverine Hydrochloride/Phentolamine Mesylate/Atropine Sulfate InjectionFusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical · D-0932-2020Class IITerminatedMar 11, 2020Alprostadil/Papaverine Hydrochloride/Phentolamine Mesylate/Atropine Sulfate InjectionFusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical · D-0933-2020Class IITerminatedMar 11, 2020Alprostadil/Papaverine Hydrochloride/Phentolamine Mesylate/Atropine Sulfate InjectionFusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical · D-0934-2020Class IITerminatedMar 11, 2020AlprostadilFusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical · D-0935-2020Class IITerminatedMar 11, 2020AlprostadilFusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical · D-0936-2020Class IITerminatedMar 11, 2020Alprostadil/Papaverine Hydrochloride/Phentolamine Mesylate Injection 20MCG/30MG/1MG/ML InjectableFusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical · D-0937-2020Class IITerminatedMar 11, 2020Alprostadil/Papaverine Hydrochloride/Phentolamine Mesylate Injection 40MCG/30MG/2MG/ML InjectableFusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical · D-0938-2020Class IITerminatedMar 11, 2020AscorbiXFusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical · D-0939-2020Class IITerminatedMar 11, 2020AscorbiXFusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical · D-0940-2020Class IITerminatedMar 11, 2020B-COMPLEX 110 INJECTABLEFusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical · D-0941-2020Class IITerminatedMar 11, 2020BETAMETHASONE ACETATE/BETAMETHASONEFusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical · D-0942-2020Class IITerminatedMar 11, 2020BETAMETHASONE ACETATE/BETAMETHASONEFusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical · D-0943-2020
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.